Literature DB >> 3709213

Comparison of intramuscular buprenorphine and a buprenorphine/naloxone combination in the treatment of post-operative pain.

B Vanacker, E Vandermeersch, J Tomassen.   

Abstract

The analgesic efficacy and tolerance of a single intramuscular injection of either buprenorphine (0.3 mg) or a buprenorphine (0.3 mg)/naloxone (0.2 mg) combination was compared in 70 patients suffering from moderate to severe pain after abdominal surgery. Patients in both treatment groups experienced good analgesia which was apparent within 10 minutes of administration and lasted for approximately 12 hours. The most frequently reported unwanted effects were drowsiness and/or sleepiness and nausea and/or vomiting which were of mild or moderate severity in most cases. No significant differences were seen between the two treatment groups with regard to the overall assessments of efficacy and tolerance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3709213     DOI: 10.1185/03007998609110432

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  6 in total

Review 1.  Buprenorphine and naloxone for heroin dependence.

Authors:  R E Johnson; J C McCagh
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

2.  Intranasal Opioid Administration in Rhesus Monkeys: PET Imaging and Antinociception.

Authors:  Phillip A Saccone; Angela M Lindsey; Robert A Koeppe; Kathy A Zelenock; Xia Shao; Phillip Sherman; Carole A Quesada; James H Woods; Peter J H Scott
Journal:  J Pharmacol Exp Ther       Date:  2016-09-13       Impact factor: 4.030

3.  Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system.

Authors:  Roberto Ciccocioppo; Daina Economidou; Roberto Rimondini; Wolfgang Sommer; Maurizio Massi; Markus Heilig
Journal:  Biol Psychiatry       Date:  2006-03-14       Impact factor: 13.382

4.  Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat.

Authors:  Daina Economidou; Anita C Hansson; Friedbert Weiss; Anton Terasmaa; Wolfgang H Sommer; Andrea Cippitelli; Amalia Fedeli; Rèmi Martin-Fardon; Maurizio Massi; Roberto Ciccocioppo; Markus Heilig
Journal:  Biol Psychiatry       Date:  2008-03-25       Impact factor: 13.382

5.  Buprenorphine and naloxone alone and in combination in opioid-dependent humans.

Authors:  K L Preston; G E Bigelow; I A Liebson
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Multimodal assessment of sleep in men and women during treatment for opioid use disorder.

Authors:  Patrick H Finan; Chung Jung Mun; David H Epstein; William J Kowalczyk; Karran A Phillips; Daniel Agage; Michael T Smith; Kenzie L Preston
Journal:  Drug Alcohol Depend       Date:  2019-11-18       Impact factor: 4.852

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.